IgLON5 autoimmunity tested negative in patients with progressive supranuclear palsy and corticobasal syndrome

被引：16

作者：

Mangesius, Stephanie ^{[1
,2
]}

Sprenger, Fabienne ^{[1
]}

Hoftberger, Romana ^{[3
]}

Seppi, Klaus ^{[1
]}

Reindl, Markus ^{[1
]}

Poewe, Werner ^{[1
]}

机构：

[1] Med Univ Innsbruck, Dept Neurol, Innsbruck, Austria

[2] Med Univ Innsbruck, Dept Neuroradiol, Innsbruck, Austria

[3] Med Univ Vienna, Inst Neurol, Vienna, Austria

来源：

PARKINSONISM & RELATED DISORDERS | 2017年 / 38卷

关键词：

Progressive supranuclear palsy; Corticobasal syndrome; Autoimmune diseases; Sleep disorders; IgLON5; DIAGNOSIS; CRITERIA;

D O I：

10.1016/j.parkreldis.2017.03.002

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：102 / 103

页数：2

共 50 条

[41] Digital Speech Analysis in Progressive Supranuclear Palsy and Corticobasal Syndromes [J].

Parjane, Natalia ;

Cho, Sunghye ;

Ash, Sharon ;

Cousins, Katheryn A. Q. ;

Shellikeri, Sanjana ;

Liberman, Mark ;

Shaw, Leslie M. ;

Irwin, David J. ;

Grossman, Murray ;

Nevler, Naomi .

JOURNAL OF ALZHEIMERS DISEASE, 2021, 82 (01) :33-45

[42] Key emerging issues in progressive supranuclear palsy and corticobasal degeneration [J].

Josephs, Keith A. .

JOURNAL OF NEUROLOGY, 2015, 262 (03) :783-788

[43] Progressive Supranuclear Palsy and Corticobasal Degeneration: Pathophysiology and Treatment Options [J].

Ruth Lamb ;

Jonathan D. Rohrer ;

Andrew J. Lees ;

Huw R. Morris .

Current Treatment Options in Neurology, 2016, 18

[44] Differentiating Progressive Supranuclear Palsy and Corticobasal Syndrome: Insights from Cerebrospinal Fluid Biomarkers-A Narrative Review [J].

Giannakis, Alexandros ;

Konitsiotis, Spiridon ;

Sioka, Chrissa .

MEDICINA-LITHUANIA, 2025, 61 (04)

[45] Astrocytic inclusions in progressive supranuclear palsy and corticobasal degeneration [J].

Yoshida, Mari .

NEUROPATHOLOGY, 2014, 34 (06) :555-570

[46] Clinical features differentiating patients with postmortem confirmed progressive supranuclear palsy and corticobasal degeneration [J].

I. Litvan ;

D. A. Grimes ;

A. E. Lang ;

J. Jankovic ;

A. McKee ;

M. Verny ;

K. Jellinger ;

K. R. Chaudhuri ;

R. K. B. Pearce .

Journal of Neurology, 1999, 246 (Suppl 2) :II1-II5

[47] Clinical features differentiating patients with postmortem confirmed progressive supranuclear palsy and corticobasal degeneration [J].

Litvan, I ;

Grimes, DA ;

Lang, AE ;

Jankovic, J ;

McKee, A ;

Verny, M ;

Jellinger, K ;

Chaudhuri, KR ;

Pearce, RKB .

JOURNAL OF NEUROLOGY, 1999, 246 :1-5

[48] The prevalence and incidence of progressive supranuclear palsy and corticobasal syndrome: a systematic review and meta-analysis [J].

Shane Lyons ;

Dominic Trépel ;

Tim Lynch ;

Richard Walsh ;

Sean O’Dowd .

Journal of Neurology, 2023, 270 :4451-4465

[49] Subcutaneous apomorphine in the treatment of progressive supranuclear palsy and corticobasal syndrome: A preliminary study of 7 cases [J].

Hubsch, Cecile ;

Mari, Marc Ziegler Ivan ;

Leguillier, Teddy ;

Lebouteux, Marie ;

Brandel, Jean-Philippe .

PARKINSONISM & RELATED DISORDERS, 2022, 95 :98-99

[50] Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration [J].

D. W. Dickson .

Journal of Neurology, 1999, 246 (Suppl 2) :II6-II15

← 1 2 3 4 5 →